Antagonists of aldosterone: A novel approach to reducing proteinuria in patients with chronic kidney disease?

被引：0
作者：
Bianchi, S
Bigazzi, R
Campese, VM
机构：
[1] Spedali Riuniti Livorno, Unita Operativa Nefrol, Livorno, Italy
[2] USC, Keck Sch Med, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2005年 / 18卷 / 05期
关键词：
aldosterone antagonists; chronic kidney disease; proteinuria;
D O I：
10.1016/j.amjhyper.2005.03.014
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：6A / 6A
页数：1
相关论文
共 50 条
[41]   Circulating Matrix Metalloproteinase-2 Is an Independent Correlate of Proteinuria in Patients with Chronic Kidney Disease [J].
Nagano, Makio ;
Fukami, Kei ;
Yamagishi, Sho-ichi ;
Ueda, Seiji ;
Kaida, Yusuke ;
Matsumoto, Takafumi ;
Yoshimura, Junko ;
Hazama, Takuma ;
Takamiya, Yoshimi ;
Kusumoto, Takuo ;
Gohara, Shojiro ;
Tanaka, Hideharu ;
Adachi, Hisashi ;
Okuda, Seiya .
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (02) :109-115
[42]   The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease [J].
Shen, Wen ;
Alshehri, Mohammed ;
Desale, Sameer ;
Wilcox, Christopher .
AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (05) :368-377
[43]   Endothelin antagonists and resistant hypertension in chronic kidney disease [J].
Moore, Rebecca ;
Linas, Stuart .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (05) :432-436
[44]   Efonidipine Reduces Proteinuria and Plasma Aldosterone in Patients with Chronic Glomerulonephritis [J].
Toshihiko Ishimitsu ;
Tomoko Kameda ;
Akira Akashiba ;
Toshiaki Takahashi ;
Satoshi Ohta ;
Masayoshi Yoshii ;
Junichi Minami ;
Hidehiko Ono ;
Atsushi Numabe ;
Hiroaki Matsuoka .
Hypertension Research, 2007, 30 :621-626
[45]   Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis [J].
Ishimitsu, Toshihiko ;
Kameda, Tornoko ;
Akashiba, Akira ;
Takahashi, Toshiaki ;
Ohta, Satoshi ;
Yoshii, Masayoshi ;
Minami, Junichi ;
Ono, Hidehiko ;
Numabe, Atsushi ;
Matsuoka, Hiroaki .
HYPERTENSION RESEARCH, 2007, 30 (07) :621-626
[46]   Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction? [J].
Athyrost, Vasilios G. ;
Katsiki, Niki ;
Karagiannis, Asterios ;
Mikhailidis, Dimitri P. .
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (10) :1449-1461
[47]   Aldosterone synthase inhibition in chronic kidney disease [J].
Theodorakopoulou, Marieta P. ;
Iatridi, Fotini ;
Sarafidis, Pantelis A. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2025, 34 (05) :360-367
[48]   Aldosterone in chronic kidney disease and renal outcomes [J].
Verma, Ashish ;
Vaidya, Anand ;
Subudhi, Sonu ;
Waikar, Sushrut S. .
EUROPEAN HEART JOURNAL, 2022, 43 (38) :3781-3791
[49]   STRATEGIES FOR CONTROLLING BLOOD PRESSURE AND REDUCING CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE [J].
Norris, Keith C. ;
Nicholas, Susanne B. .
ETHNICITY & DISEASE, 2015, 25 (04) :515-520
[50]   Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension [J].
Kiichiro Fujisaki ;
Kazuhiko Tsuruya ;
Toshiaki Nakano ;
Masatomo Taniguchi ;
Harumichi Higashi ;
Ritsuko Katafuchi ;
Hidetoshi Kanai ;
Masaru Nakayama ;
Hideki Hirakata ;
Takanari Kitazono .
Hypertension Research, 2014, 37 :993-998
12345